~~<i id='08375B5E8D'><strike id='08375B5E8D'><tt id='08375B5E8D'><pre id='08375B5E8D'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：entertainment 2025-10-03 00:42:27 Page View：93383

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： CMS got Medicare Advantage quality rating wrong, judge rules
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

explore

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

PBMs drew scrutiny in House hearing — and so did pharma

Rep.JamesComer,chairoftheHouseOversightCommitteeKevinDietsch/GettyImagesWASHINGTON—Congresswantstore

Bright Health sells Medicare Advantage business to Molina

BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

Senate bill would ban some hospital facility fees

Sen.BernieSanders(I-Vt.)andaRepublicancolleagueintroducedmeasurestoreformhospitalcontractingandbanso